
Loading, please wait...

Loading, please wait...

Ageism significantly impacts the physical and mental health of the elderly in India. Most anti-ageism interventions primarily focus on the attitudes of younger generations. While education and intergenerational contact effectively reduce prejudice, researchers frequently neglect the experiences of older participants. Consequently, experts argue that this oversight is a significant missed opportunity. By ignoring the older demographic, programs fail to address how interactions improve older adults' self-perceptions. Furthermore, a systematic review reveals that only a small number of studies assess the impact on older participants. These limited findings are promising, as they suggest that engagement leads to better social inclusion. However, the current body of research suffers from significant theoretical and empirical weaknesses. Therefore, scholars must elevate the attention given to older participants to ensure programs provide mutual benefits.
In addition, programs must have clear theoretical foundations that identify expected outcomes for all participants. Strengthening research designs and measurement tools is essential for promoting a collaborative society. Doctors can lead this change by advocating for inclusive practices that value the participation of older adults. Ultimately, this approach will result in better health outcomes and a more respectful society.
These interventions can improve older adults' attitudes toward younger people, reduce the internalization of negative aging stereotypes, and potentially improve psychological well-being through social engagement.
Programs that combine educational components with structured, positive intergenerational contact often prove most effective in reducing ageist attitudes across all age groups.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Morrow-Howell N et al. There, but Not There: Older People in Anti-Ageism Interventions. Gerontologist. 2026 Feb 15. doi: undefined. PMID: 41693028.
Apriceno M, Levy SR. Systematic Review and Meta-Analyses of Effective Programs for Reducing Ageism Toward Older Adults. J Appl Gerontol. 2023 Jun;42(6):1356-1375.
World Health Organization. Global report on ageism. Geneva: World Health Organization; 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Research highlights a critical gap in anti-ageism interventions, urging a focus on the outcomes and experiences of older participants for inclusive healthca...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today